User profiles for B Moum
 | Bjørn Moum, Professor & ConsultantOslo university hospital & University of Oslo, NO Verified email at medisin.uio.no Cited by 17516 |
Geographical variability and environmental risk factors in inflammatory bowel disease
…, PL Lakatos, EV Loftus, C Tysk, C O'Morain, B Moum… - Gut, 2013 - gut.bmj.com
The changing epidemiology of inflammatory bowel disease (IBD) across time and geography
suggests that environmental factors play a major role in modifying disease expression. …
suggests that environmental factors play a major role in modifying disease expression. …
Hospitalisations and surgery in Crohn's disease
Hospitalisation and surgery are considered to be markers of more severe disease in Crohn's
disease. These are costly events and limiting these costs has emerged as one rationale for …
disease. These are costly events and limiting these costs has emerged as one rationale for …
Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis
…, S Lindgren, F Morena, B Moum… - Inflammatory Bowel …, 2014 - academic.oup.com
Background The main objective is to determine the overall prevalence of anemia in inflammatory
bowel diseases (IBD) in Europe. Methods A systematic literature search in PubMed …
bowel diseases (IBD) in Europe. Methods A systematic literature search in PubMed …
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised …
…, JR Kruse, MKA Ljoså, IP Midtgard, P Mielnik, B Moum… - The Lancet, 2017 - thelancet.com
Background TNF inhibitors have improved treatment of Crohn's disease, ulcerative colitis,
spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis, but are …
spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis, but are …
Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort
Background & Aims: Mucosal healing (MH) in inflammatory bowel disease may be an important
sign of efficacy of treatment and a prognostic marker of long-term disease. The aim of the …
sign of efficacy of treatment and a prognostic marker of long-term disease. The aim of the …
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
…, M Henriksen, J Sauar, MH Vatn, B Moum… - Scandinavian journal …, 2009 - Taylor & Francis
Objective. Cohort studies of unselected and newly diagnosed patients are essential for a
better understanding of the prognosis in ulcerative colitis (UC). The aim of this study was to …
better understanding of the prognosis in ulcerative colitis (UC). The aim of this study was to …
Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study
Background & Aims: Most studies concerning the clinical course in CD are retrospective or
based on selected patient groups. Our aim was to assess the course of CD in a prospective …
based on selected patient groups. Our aim was to assess the course of CD in a prospective …
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study
… The NOD family of proteins is mainly expressed in monocytes, macrophages, and B cells. …
C Solberg, J Jahnsen, and B Moum did phenotype analysis and patient follow-up. …
C Solberg, J Jahnsen, and B Moum did phenotype analysis and patient follow-up. …
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
…, I Lygren, N Stray, J Sauar, MH Vatn, B Moum… - Gut, 2008 - gut.bmj.com
Background and aims: C-reactive protein (CRP) levels are often used in the follow-up of
patients with inflammatory bowel disease (IBD). The aims of this study were to establish the …
patients with inflammatory bowel disease (IBD). The aims of this study were to establish the …
Management of patients with Crohn's disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting
…, GJ Mantzaris, DP McGovern, BA Moum… - …, 2020 - gastrojournal.org
The 2020 annual meeting for IOIBD was scheduled to occur in March, but was cancelled
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …